The DCP Organ Systems Research Groups develop, support and oversee clinical cancer prevention trials and promote participation by all populations. The trials are designed to evaluate the safety and efficacy of promising new preventive agents, the utility of novel biomarkers, and the value of innovative technologies to identify premalignant lesions. The Early Phase Cancer Prevention Clinical Trials Program facilitated through Consortia contracts and the grant funded Cancer Prevention Clinical Trials Network (CP-CTNet) were created to facilitate the efficient implementation of these studies by teams of multidisciplinary investigators. The purpose of the meeting is to stimulate information sharing and collaborations between DCP staff and Consortia/CP-CTNet members including investigators, program staff and coordinators; and to develop strategies to enhance the cancer prevention intervention research program both scientifically and operationally.
Registration is required.